Arena (ARNA) Ramps as PDUFA Delay May Be Avoided
Tweet Send to a Friend
With just eight more days until Arena Pharmaceuticals' (NASDAQ: ARNA) FDA PDUFA date (06/27) for potential blockbuster obesity drug Lorcaserin, investors may be feeling more confident that a 3-6 month delay won't come.
Looking at the past announcement from rival Vivus, Inc. (NASDAQ: VVUS) of a three month PDUFA delay for its Qnexa, it should be noted that the delay announcement came eight days ahead of the original scheduled PDUFA date.
This could suggest that if we don't get a delay announcement from Arena today, it won't come at all.
With or without a delay, most expected the FDA will follow the advice of their panel and back Lorcaserin. However, if the company doesn't get the delay it may be able to gain a 'first to market' advantage.
Shares of ARNA last traded at $10.17, up 8.4 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Looking at the past announcement from rival Vivus, Inc. (NASDAQ: VVUS) of a three month PDUFA delay for its Qnexa, it should be noted that the delay announcement came eight days ahead of the original scheduled PDUFA date.
This could suggest that if we don't get a delay announcement from Arena today, it won't come at all.
With or without a delay, most expected the FDA will follow the advice of their panel and back Lorcaserin. However, if the company doesn't get the delay it may be able to gain a 'first to market' advantage.
Shares of ARNA last traded at $10.17, up 8.4 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Fannie Mae, Freddie Mac Surge as Seriously Delinquent Rate Falls Below 3%
- Mannkind (MNKD) Continues Higher
- Highway Holdings (HIHO) Surges, Halted on $400K Per Year Order
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)